Delcath Systems Inc - ESG Rating & Company Profile powered by AI
Other companies in the rating peer group for Delcath Systems Inc are displayedin the table. The assessment of Delcath Systems Inc is prepared by All Street Sevva using advanced NLP. This webpage contains a questions and answers section on Delcath Systems Inc.
Delcath Systems Inc in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Bioteque Corp | 8.0 | High |
| 1 | Amplitude Surgical SA | 8.0 | High |
| ... | ... | ... | |
| 378 | Guangzhou Wondfo Biotech Co Ltd | 0.4 | Low |
| 379 | C R Bard Inc | 0.3 | Low |
| 380 | Delcath Systems Inc | 0.0 | Low |
| 380 | CU Medical Systems Inc | 0.0 | Low |
| 380 | Calypte Biomedical Corp | 0.0 | Low |
| 380 | ZoomMed Inc | 0.0 | Low |
| 380 | iRay Technology Co Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Delcath Systems Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Delcath Systems Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Delcath Systems Inc report the average age of the workforce?
Sign up for free to unlockDoes Delcath Systems Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Delcath Systems Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Delcath Systems Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Delcath Systems Inc offer flexible work?
Sign up for free to unlockDoes Delcath Systems Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Delcath Systems Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Delcath Systems Inc conduct supply chain audits?
Sign up for free to unlockDoes Delcath Systems Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Delcath Systems Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Delcath Systems Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Delcath Systems Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Delcath Systems Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Delcath Systems Inc disclose water use targets?
Sign up for free to unlockDoes Delcath Systems Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Delcath Systems Inc have a product recall in the last two years?
Sign up for free to unlockDoes Delcath Systems Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Delcath Systems Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Delcath Systems Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Delcath Systems Inc disclose parental leave metrics?
Sign up for free to unlockDoes Delcath Systems Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Delcath Systems Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Delcath Systems Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Delcath Systems Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Delcath Systems Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Delcath Systems Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Delcath Systems Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Delcath Systems Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Delcath Systems Inc disclose its waste policy?
Sign up for free to unlockDoes Delcath Systems Inc report according to TCFD requirements?
Sign up for free to unlockDoes Delcath Systems Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Delcath Systems Inc disclose energy use targets?
Sign up for free to unlockDoes Delcath Systems Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Delcath Systems Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Delcath Systems Inc
These potential risks are based on the size, segment and geographies of the company.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.